Vedolizumab for treating moderately to severely active Crohn's disease in people 2 to 17 years [TSID12312]

Status:

Topic prioritisation

Technology type:

Medicine

Decision:

Awaiting decision

Prioritisation programme:

Medicines evaluation

Rationale:

This topic is awaiting a decision.

ID number:

12312

Project Team

Project lead

Danielle Lees

Email enquiries

If you have any queries please email topic.selection@nice.org.uk

Timeline

Key events during the development of the guidance:

For further information on how we select topics for development, please see our page about topic prioritisation